Prioritising injectable therapies in the management of type 2 diabetes.

Lancet Diabetes Endocrinol

National Research Institute, Los Angeles, CA 90057, USA. Electronic address:

Published: July 2019

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(19)30117-2DOI Listing

Publication Analysis

Top Keywords

prioritising injectable
4
injectable therapies
4
therapies management
4
management type
4
type diabetes
4
prioritising
1
therapies
1
management
1
type
1
diabetes
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!